According to Fortune Business Insights, the global leukapheresis market share is witnessing steady growth driven by increasing demand for blood component separation procedures, rising prevalence of hematologic disorders, and expanding adoption of cell-based therapies. The market was valued at USD 621.4 million in 2025 and is projected to reach USD 1,059.3 million by 2034, expanding at a CAGR of 6.0% during the forecast period. North America dominated the market with a share of 36.71% in 2025, supported by advanced healthcare infrastructure, growing clinical research activities, and increasing utilization of apheresis technologies.
Leukapheresis is a medical procedure used to separate and collect white blood cells (leukocytes) from blood. It is widely utilized in therapeutic treatments, blood donation procedures, stem cell collection, immunotherapy, and CAR-T cell therapy manufacturing. Increasing focus on advanced biologics and cellular therapies is significantly contributing to market expansion.
MARKET DYNAMICS
Market Drivers
Growing Adoption of Cell and Gene Therapies
Increasing use of leukapheresis in CAR-T cell therapy production, stem cell transplantation, and immunotherapy applications is driving market growth.
Market Restraints
High Procedure and Equipment Costs
Advanced leukapheresis instruments and treatment procedures can involve substantial operational and maintenance costs.
Market Opportunities
Expansion of Personalized Medicine and Immunotherapy Research
Growing investments in precision medicine, oncology research, and regenerative therapies are creating strong opportunities for leukapheresis technologies.
Market Challenges
Limited Availability of Skilled Healthcare Professionals
The procedure requires trained personnel and specialized clinical settings, which may limit adoption in certain regions.
Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/leukapheresis-market-115796
LEUKAPHERESIS MARKET TRENDS
Increasing Utilization in CAR-T Cell and Stem Cell Therapies
Healthcare providers and biotechnology companies are increasingly using leukapheresis for collecting immune cells in advanced therapeutic applications.
SEGMENTATION ANALYSIS
By Product Type
The market includes instruments and consumables.
- Consumables: Dominate the market due to recurring demand for tubing sets, filters, anticoagulants, and disposable kits during procedures.
- Instruments: Growing steadily with increasing adoption of automated apheresis systems in hospitals and blood centers.
By Procedure Type
The market includes donor leukapheresis and therapeutic leukapheresis.
- Donor Leukapheresis: Holds a major market share due to rising blood component donation and stem cell collection procedures.
- Therapeutic Leukapheresis: Growing steadily for treatment of leukemia, autoimmune disorders, and hyperleukocytosis conditions.
By Technology Platform
Technology platforms include centrifugation, membrane filtration, and others.
- Centrifugation: Dominates the market due to its high efficiency and widespread adoption in clinical and blood banking applications.
- Membrane Filtration: Growing gradually with advancements in filtration technologies and minimally invasive blood separation systems.
By End User
End users include hospitals, specialty clinics, blood collection centers & blood banks, and others.
- Hospitals: Hold the largest market share due to increasing therapeutic and oncology-related leukapheresis procedures.
- Blood Collection Centers & Blood Banks: Growing steadily with rising blood donation and cellular therapy collection activities.
- Specialty Clinics: Increasingly adopting leukapheresis technologies for specialized therapeutic applications.
REGIONAL ANALYSIS
North America
North America dominates the market due to advanced healthcare infrastructure, increasing cell therapy research, and strong presence of biotechnology companies and blood collection organizations.
Europe
Europe is witnessing steady growth driven by expanding stem cell research and increasing adoption of immunotherapy treatments.
Asia Pacific
Asia Pacific is expected to grow rapidly due to improving healthcare infrastructure, rising cancer prevalence, and increasing investments in regenerative medicine and biotechnology.
Latin America
Latin America is experiencing gradual growth supported by growing awareness regarding blood component therapies and healthcare modernization.
Middle East & Africa
The Middle East & Africa region is witnessing moderate growth due to increasing healthcare investments and rising adoption of advanced therapeutic procedures.
Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/leukapheresis-market-115796
COMPETITIVE LANDSCAPE
- Terumo Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Asahi Kasei Medical Co., Ltd.
- Baxter International Inc.
- B. Braun Melsungen AG
- Macopharma SA
- HemaCare Corporation
- Kaneka Corporation
- STEMCELL Technologies Inc.
REPORT COVERAGE
The leukapheresis market report provides insights into market size, segmentation, regional outlook, and competitive landscape. It highlights trends such as CAR-T therapy expansion, automated apheresis systems, and increasing cell therapy research activities. Rising adoption of immunotherapy and precision medicine is expected to support long-term market growth during the forecast period.